Skip to main content
OpenTrials
Completed

NCT Number: NCT01654302

Efficacy and Safety of Synera in Osteoarthritis Pain

Knee osteoarthritis (OA) can result in significant pain and limitation of function. A number of topical non-steroidal anti-inflammatory drugs have been shown to reduce pain in this condition. This study examines a different topical approach, utilizing a topical anesthetic agent, to evaluate if application of such an agent would provide relief of exercise-induced knee pain in people with knee OA.

Completed

Looking for future studies?

Notify Me

Key information

Age range

40 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1 / Phase 2

Primary location

Northwestern University

Chicago, Illinois, 60611, United States

About this study

Subjects participated in two visits each at least 1 week apart, where they underwent two exercise interventions - a baseline exercise without treatment and a experimental exercise with intervention (Synera patch or Inactive patch). Participants rated their pain on a NRS-11 1 minute, 5 minutes, and 60 minutes after both exercises, as well as 6 hours after the experimental exercise, before bedtime, and the following morning. Subjects were randomized to receive either Synera at the first visit and the inactive patch at the second visit or the inactive patch at the first visit and Synera patch at the second visit.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Men and women, age 40 years and above
  • Meet American College of Rheumatology criteria for knee OA
  • Knee pain most days of the week for the past month
  • Knee pain > 5/10 after exercise intervention
  • Capable of undertaking exercise intervention
  • Stable cardiovascular function
  • Able to return for all clinic visits
  • Able to read and understand the informed consent document

Exclusion criteria

  • Use of a walker to ambulate or inability to ambulate
  • Other forms of arthritis
  • Other major causes of pain that could be expected to interfere with assessment of pain during this trial, e.g., recurrent migraine, back pain, fibromyalgia
  • History of myocardial infarction
  • Blood Pressure > 140 systolic/100 diastolic
  • Scheduled for and likely to need joint replacement surgery in the next 3 months
  • Any medical condition that in the judgment of the investigator would make the participant not suitable for the study
  • Sensitivity to lidocaine, topical or injectable analgesics/anesthetics.

Treatment and study plan

Synera

Drug

70 mg lidocaine/ 70 mg tetracaine topical patch applied once for 12 hours

Other names: lidocaine/tetracaine

Inactive patch

Drug

placebo patch applied once for 12 hours

Other names: placebo

Primary outcomes

  1. Index Knee Pain Scores on a Numeric Rating Scale (NRS)

    Time frame: 5 minutes after stopped exercise, performed 1 hour after intervention (patch application)

    Subject rated index knee pain 5 minutes after stopped experimental exercise (with intervention). Index knee pain was reported using the Numeric Rating Scale, a scale from 0 to 10 where 0 = no pain and 10 = the worst pain possible.

Sponsors and collaborators

Lead sponsor

Thomas J. Schnitzer

Other

Collaborators

  • Nuvo Research Inc.

Registry information

Official study title

Efficacy and Safety of Synera in OA Pain

Important dates

Study start
2013
Primary completion
2014
Study completion
2015
First posted
Jul 31, 2012
Registry last updated
May 12, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.